SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 10/21/2024 at 07:30, 1 year 8 months ago

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R partner to fuel Opella's ambitions in consumer healthcare as Sanofi transfers a 50% stake in Opella. Opella to become a standalone leader backed by Sanofi's strategic support and guidance

Partnership Sanofi CD&R Consumer Healthcare Opella
BRIEF

published on 10/15/2024 at 22:10, 1 year 8 months ago

Sanofi Reports Share and Voting Rights Data for September 2024

Voting Rights Investor Information Sanofi September 2024 Shares Data
PRESS RELEASE

published on 10/15/2024 at 22:05, 1 year 8 months ago

Sanofi: Information concerning the total number of voting rights and shares - September 2024
Sanofi reports total number of voting rights and shares as of September 30, 2024, in compliance with French commercial and stock market regulations

Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
BRIEF

published on 10/11/2024 at 08:35, 1 year 8 months ago

Sanofi considers selling majority stake in Opella

Participations Health Sanofi CD&R Opella
PRESS RELEASE

published on 10/11/2024 at 08:30, 1 year 8 months ago

Press Release: Sanofi in discussions to sell a controlling stake in Opella
Sanofi is in discussions to sell a controlling stake in Opella, its consumer healthcare business, to CD&R. Opella aims for independence aligning with Sanofi’s focus on innovative medicines and vaccines

Negotiations Sale Sanofi Consumer Healthcare Opella
BRIEF

published on 10/09/2024 at 07:05, 1 year 9 months ago

Sanofi Highlights Beyfortus Effectiveness Against RSV in Infants

Sanofi RSV Beyfortus Infants IDWeek 2024
PRESS RELEASE

published on 10/09/2024 at 07:00, 1 year 9 months ago

Press Release: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants
Sanofi presents new Beyfortus data at IDWeek 2024, showcasing real-world effectiveness in protecting infants from RSV disease and hospitalization. Beyfortus doses shipped for 2024-2025 RSV season

Sanofi RSV Beyfortus Infants IDWeek
BRIEF

published on 09/27/2024 at 15:40, 1 year 9 months ago

Dupixent Approved in the US as First Biologic for COPD Patients

FDA Approval Clinical Studies COPD Dupixent Biologic Medicine
PRESS RELEASE

published on 09/27/2024 at 15:35, 1 year 9 months ago

Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
US FDA approves Dupixent as the first-ever biologic medicine for COPD, based on phase 3 studies showing significant reduction in exacerbations and improved lung function. Dupixent is now leading in new-to-brand prescriptions for FDA-approved indications

FDA Approval Dupixent COPD Treatment Biologic Medicine Phase 3 Studies
BRIEF

published on 09/27/2024 at 13:05, 1 year 9 months ago

Dupixent Authorized in China as First Biologic Medicine for COPD Patients

China Approval COPD Dupixent Biologic Medicine

Published on 07/10/2026 at 15:00, 36 minutes ago

First Canadian Graphite Inc Corporate Update
Published on 07/10/2026 at 14:20, 1 hour 16 minutes ago

Giyani Announces Filing of Definitive Feasibility Study
Published on 07/10/2026 at 14:00, 1 hour 36 minutes ago

Orogen Royalties Begins Trading on OTCQX Best Market
Published on 07/10/2026 at 13:30, 2 hours 6 minutes ago

Empress Announces Acquisition of North American Royalty Portfolio
Published on 07/10/2026 at 13:30, 2 hours 6 minutes ago

Caldwell Appoints John Blank as Chief Operating Officer and Names Regional Managing Partners

View all ACCESSWIRE

Published on 07/10/2026 at 15:26, 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 07/10/2026 at 15:25, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 07/10/2026 at 15:24, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 07/10/2026 at 15:23, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 07/10/2026 at 15:22, 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc

View all EQS

Published on 07/10/2026 at 10:34, 5 hours 1 minute ago

Number of shares and voting rights - June 2026 (In French only)
Published on 07/09/2026 at 18:00, 21 hours 36 minutes ago

Second-quarter 2026 activity: +7% (vs. Q2 2025)
Published on 07/09/2026 at 18:00, 21 hours 36 minutes ago

Half-year report on Deezer’s liquidity contract with BNP Paribas
Published on 07/09/2026 at 17:45, 21 hours 51 minutes ago

Air Liquide to invest over 200M USD to support chemical manufacturing expansion in Texas
Published on 07/09/2026 at 15:50, 23 hours 45 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of June 30, 2026

View all LES ECHOS COMFI WIRE

News